The UK Medicines and Healthcare products Regulatory Agency (MHRA) is issuing a patient alert card for men prescribed finasteride. The card is intended to raise awareness of the drug’s psychiatric side effects and sexual dysfunction, including the possibility that sexual dysfunction may continue after treatment is stopped.
Regulatory UpdatesAug 25, 2026•1 min read
MHRA Introduces Patient Alert Card for Finasteride Users
A new patient alert card warns men on finasteride of psychiatric side effects and persistent sexual dysfunction.
Compiled by the PharmaCountry team · Source: MHRA
Ratings
(0)
(0)
(0)
(0)
(0)
More articles
View all insightsResearch & Reports
Global Finished Dosage Manufacturing Landscape 2026
Oct 5, 2026
Regulatory UpdatesKorea Korus hit with 1‑month manufacturing suspension over missing post‑marketing safety test
Sep 28, 2026
AnalysisPharma distributors set delivery cut‑offs ahead of Chuseok holiday (Sep 21‑23)
Sep 28, 2026
Leave your rating